Venture capital poured into medical and healthcare startups integrating AI – MoneyToday

Venture capital poured into medical and healthcare startups integrating AI - MoneyToday

[For more diverse corporate information on the startups featured in this article, visit the Unicorn Factory big data platform ‘Data Lab‘.]

Startup fundraising status for the third week of November / Graphic by Kim Hyeon-jung
Startup fundraising status for the third week of November / Graphic by Kim Hyeon-jung

The domestic venture capital market saw a string of investment news in the medical and healthcare sector during the third week of November (16-20). Most investments were directed at medical and healthcare businesses integrating AI, such as endoscopic AI robots, AI for medical image diagnosis, and AI-based personalized healthcare solutions, rather than traditional bio fields like new drugs.

In addition, news of strategic investments (SI) through corporations or corporate venture capital (CVC) was also frequent. Companies that announced fundraising during this period included △Mediintech, Extol, Hexarobotics, Sumbit AI, Sacak, Mannyfast, Oncovision AI, AABC Bio, Proground, At Home, Soldoc, Skybridge Global, Coils, and Nubinda.

Mediintech raises 33.8 billion won in Series C investment

/ Photo provided by Mediintech
/ Photo provided by Mediintech

Medical robotics startup Mediintech raised 33.8 billion won in a Series C round. Including this, the cumulative amount of investment received by Mediintech is 62.2 billion won. The company stated that it is currently discussing additional investments for the Series C round.

This round was co-led by existing investor Atinum Investment and new investor KB Investment. Existing investors such as Smilegate Investment, SL Investment, ICF (Nextlance), and Woo Shin Venture Investment also participated in follow-on investments, while K2 Investment Partners joined as a new investor.

Founded in 2020, Mediintech has been developing AI robotic endoscopes that combine robot precision control technology and AI with digestive endoscopy. Its flagship product, ‘Intion S,’ is characterized by the application of motor-based precision control technology, unlike conventional methods where medical staff manually pull a wire to adjust the direction of the endoscope.

Mediintech expanded the scope of AI utilization from image analysis to controlling the actual movement of medical devices. The company explained that it has implemented autonomous steering technology that connects information recognized by AI to the movement of the endoscope. This reduces the operational burden on medical staff and assists in diagnosis by adjusting the direction of the endoscope’s progression and tracking lesions.

Lee Chi-won, CEO of Mediintech, said, “We will expand the domestic and international supply of AI robotic endoscopes and advance autonomous steering and precision control technologies to build a next-generation medical robotics platform that extends from diagnosis to treatment and surgery.”

“Will become essential infrastructure for radiology departments” Sumbit AI raises 12 billion won

/ Photo by Sumbit AI
/ Photo by Sumbit AI

Sumbit AI, a company providing medical image diagnosis solutions based on generative AI, raised 12 billion won in a Series A round from SV Investment, Altor Ventures, Kiwoom Investment, and iM Investment Partners.

Sumbit AI was established in July 2024 by a team that developed the chest X-ray diagnosis assistance AI business at Kakao Brain. CEO Bae Woong, who served as Chief Healthcare Officer (CHO) at Kakao Brain, co-founded the company with former Kakao Brain members.

Its current flagship product is ‘AIRead-CXR,’ which automatically drafts chest X-ray diagnostic reports. Trained on approximately 14 million domestic and international chest X-ray images and diagnostic reports, it analyzes at least 57 types of findings, including pleural effusion, pneumothorax, pulmonary edema, pulmonary nodules, cardiomegaly, active tuberculosis, and rib or clavicle fractures.

The product received Class III digital medical device approval from the Ministry of Food and Drug Safety in April this year. It is the first case in Korea where a software as a medical device (SaMD) based on generative AI that directly analyzes medical images to create preliminary reports has received domestic approval.

CEO Bae Woong said, “Based on our technology for generating diagnostic report drafts using generative AI and business know-how acquired from chest X-rays, we will rapidly expand to CT and MRI to become essential infrastructure indispensable to radiologists worldwide.”

Hexarobotics receives 4 billion won equity investment from WINNER S Electric

Wearable robotics startup Hexarobotics received a 4 billion won investment from WINNER S Electric, a specialist in smart wiring devices. With this investment, WINNER S Electric became the second-largest shareholder of Hexarobotics, holding 10.52% of its shares.

WINNER S Electric signed a strategic business partnership and exclusive original equipment manufacturing (OEM) contract with Hexarobotics for wearable robot product lines last month (October). Accordingly, WINNER S Electric will exclusively handle the entire process from establishing mass production processes to producing core modules, assembling finished products, and conducting shipment inspections for the walking-assist wearable robots developed by Hexarobotics.

The two companies plan to strengthen their cooperative relationship through this equity investment and work on building a mass production system for wearable robots and jointly opening new sales channels. WINNER S Electric aims to secure new growth drivers by expanding its manufacturing and quality management capabilities, accumulated in its existing smart wiring device business, into the robotics field.

An official from WINNER S Electric said, “We will combine the technological strength and manufacturing capabilities of both companies to secure competitiveness and cultivate the robot manufacturing business as a new growth driver.”

Hyosung Ventures invests in Soldoc and At Home… targeting digital healthcare and beauty tech

/ Photo provided by Hyosung Ventures
/ Photo provided by Hyosung Ventures

Hyosung Ventures, the corporate venture capital (CVC) of the Hyosung Group, invested in digital healthcare startup Soldoc and beauty tech startup At Home.

This investment was made through the second fund, ‘Startup Korea Hyosung Deep Tech Investment Fund,’ jointly established by Hyosung Ventures and Korea Venture Investment in 2024. The fund targets promising companies in advanced technology fields such as AI and bio.

Soldoc is a digital healthcare startup providing medical services including in-person and remote appointment scheduling, reception, prescription, medical supply delivery, and nursing fee claims. It supports patients in conveniently utilizing various medical services by leveraging its self-developed Electronic Medical Record (EMR) system. Recently, it has expanded its business into medical supply distribution and building healthcare systems for government agencies and corporations.

At Home is a company that develops and sells small home appliances such as food waste processors and home beauty devices. Its major brands include ‘MINIX,’ which ranks first in the domestic home food waste processor market, and ‘THOME,’ a home beauty device brand that achieved top sales in Korea. Recently, it has expanded its product lineup to include dedicated ampoules and skincare products.

An official from Hyosung Ventures said, “We will continue investing in promising companies and actively support the growth of our portfolio companies.”

Samchully Group invests in startups Nubinda and Coils: “Cooperation on new robot business”

Samchully 'S-Together' program meetup day held at Samchully Motors Connected Center in Gunpo, Gyeonggi Province on the 13th / Photo provided by The Invention Lab
Samchully ‘S-Together’ program meetup day held at Samchully Motors Connected Center in Gunpo, Gyeonggi Province on the 13th / Photo provided by The Invention Lab

The Samchully Group selected two startups, Nubinda and Coils, for its open innovation program ‘S-Together’ and will proceed with investments.

S-Together is a startup discovery and cultivation program in fields such as energy, eco-friendly technology, and mobility, operated by Samchully Accelerator The Invention Lab. This year, over 100 companies applied to the program, and two were ultimately selected.

Nubinda, established in 2025, is a startup developing high-performance drive motors used for humanoid robot joints and future mobility applications, such as in-wheel motors.

Coils is developing multi-coil wireless charging technology compatible with various robots and drones. It was established in 2024 by engineers who have researched wireless power transfer (WPT) at KAIST.

Samchully believes that the technologies of the two companies can be applied to robot driving and charging, respectively, and plans to explore cooperation methods in new growth fields such as robotics and future mobility.

[MoneyToday Startup Media Platform ‘Unicorn Factory’]



Source link

Leave a Reply